- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Indoco Remedies Limited — Updates, 30-01-2026: Press Release
30-01-2026 | 01:23 pm
30-01-2026 | 01:23 pm
Indoco Remedies secured USFDA final approval for Lacosamide Oral Solution, a generic equivalent to Vimpat, for epilepsy treatment. This pivotal development allows marketing in the US, expanding their presence and commitment to global healthcare.
No comments yet. Be the first to comment!